Abstract

Purpose/Objectives: To evaluate the feasibility of an intervention designed to promote sleep and modify fatigue during four cycles of adjuvant breast cancer chemotherapy. Design: Prospective, repeated measures, quasi-experimental feasibility study. Setting: Midwestern urban oncology clinics. Sample: 25 women between the ages of 40-65 (X¯ = 54.3) with stage I-II breast cancer receiving doxorubicinbased chemotherapy. Methods: Each woman developed, reinforced, and revised an individualized sleep promotion plan (ISPP) with four components: sleep hygiene, relaxation therapy, stimulus control, and sleep restriction techniques. A daily diary, the Pittsburgh Sleep Quality Index, a wrist actigraph, and the Piper Fatigue Scale were used to collect data two days before and seven days after each treatment. Main Research Variables: Adherence, sleep and wake outcomes, and fatigue. Findings: Adherence rates with the components of the ISPP varied during treatments one through four: sleep hygiene (68%-78%), relaxation therapy (57%-67%), stimulus control (46%-67%), and sleep restriction (76%-80%). Mean sleep and wake outcomes at baseline, peak, and rebound times were that (a) sleep latency remained brief (less than 30 minutes per night), (b) time awake after sleep onset exceeded the desired less than 30 minutes per night, (c) sleep efficiency scores remained stable at 85%-90%, (d) total rest time remained stable at 8-10 hours per night, (e) subjective ratings of feelings on arising were stable, and (f) nighttime awakenings were 8-10 per night. Fatigue outcomes were that fatigue was stable two days after each treatment and mean daily fatigue intensity was lower at treatment three than at treatment one but rebounded at treatment four. Conclusions: The intervention was feasible, adherence rates improved over time, and most sleep and wake patterns were consistent with normal values. Revisions will focus on decreasing nighttime awakenings. Implications for Nursing: Adopting behaviors to promote sleep may assist in maintaining sleep and managing fatigue during chemotherapy.

Original languageEnglish (US)
Pages (from-to)1431-1441
Number of pages11
JournalOncology nursing forum
Volume29
Issue number10
DOIs
StatePublished - Dec 1 2002

Fingerprint

Sleep
Breast Neoplasms
Drug Therapy
Fatigue
Relaxation Therapy
Therapeutics
Piper
Feasibility Studies
Wrist
Emotions
Reference Values
Nursing

ASJC Scopus subject areas

  • Oncology(nursing)

Cite this

Feasibility of a sleep intervention during adjuvant breast cancer chemotherapy. / Berger, Ann Malone; Von Essen, Susanna G; Kuhn, Brett R; Piper, Barbara F.; Farr, Lynne; Agrawal, Sangeeta; Lynch, James C.; Higginbotham, Patti.

In: Oncology nursing forum, Vol. 29, No. 10, 01.12.2002, p. 1431-1441.

Research output: Contribution to journalArticle

Berger, Ann Malone ; Von Essen, Susanna G ; Kuhn, Brett R ; Piper, Barbara F. ; Farr, Lynne ; Agrawal, Sangeeta ; Lynch, James C. ; Higginbotham, Patti. / Feasibility of a sleep intervention during adjuvant breast cancer chemotherapy. In: Oncology nursing forum. 2002 ; Vol. 29, No. 10. pp. 1431-1441.
@article{d2cb91acb28744baa6005492f2219b07,
title = "Feasibility of a sleep intervention during adjuvant breast cancer chemotherapy",
abstract = "Purpose/Objectives: To evaluate the feasibility of an intervention designed to promote sleep and modify fatigue during four cycles of adjuvant breast cancer chemotherapy. Design: Prospective, repeated measures, quasi-experimental feasibility study. Setting: Midwestern urban oncology clinics. Sample: 25 women between the ages of 40-65 (X¯ = 54.3) with stage I-II breast cancer receiving doxorubicinbased chemotherapy. Methods: Each woman developed, reinforced, and revised an individualized sleep promotion plan (ISPP) with four components: sleep hygiene, relaxation therapy, stimulus control, and sleep restriction techniques. A daily diary, the Pittsburgh Sleep Quality Index, a wrist actigraph, and the Piper Fatigue Scale were used to collect data two days before and seven days after each treatment. Main Research Variables: Adherence, sleep and wake outcomes, and fatigue. Findings: Adherence rates with the components of the ISPP varied during treatments one through four: sleep hygiene (68{\%}-78{\%}), relaxation therapy (57{\%}-67{\%}), stimulus control (46{\%}-67{\%}), and sleep restriction (76{\%}-80{\%}). Mean sleep and wake outcomes at baseline, peak, and rebound times were that (a) sleep latency remained brief (less than 30 minutes per night), (b) time awake after sleep onset exceeded the desired less than 30 minutes per night, (c) sleep efficiency scores remained stable at 85{\%}-90{\%}, (d) total rest time remained stable at 8-10 hours per night, (e) subjective ratings of feelings on arising were stable, and (f) nighttime awakenings were 8-10 per night. Fatigue outcomes were that fatigue was stable two days after each treatment and mean daily fatigue intensity was lower at treatment three than at treatment one but rebounded at treatment four. Conclusions: The intervention was feasible, adherence rates improved over time, and most sleep and wake patterns were consistent with normal values. Revisions will focus on decreasing nighttime awakenings. Implications for Nursing: Adopting behaviors to promote sleep may assist in maintaining sleep and managing fatigue during chemotherapy.",
author = "Berger, {Ann Malone} and {Von Essen}, {Susanna G} and Kuhn, {Brett R} and Piper, {Barbara F.} and Lynne Farr and Sangeeta Agrawal and Lynch, {James C.} and Patti Higginbotham",
year = "2002",
month = "12",
day = "1",
doi = "10.1188/02.ONF.1431-1441",
language = "English (US)",
volume = "29",
pages = "1431--1441",
journal = "Oncology Nursing Forum",
issn = "0190-535X",
publisher = "Oncology Nursing Society",
number = "10",

}

TY - JOUR

T1 - Feasibility of a sleep intervention during adjuvant breast cancer chemotherapy

AU - Berger, Ann Malone

AU - Von Essen, Susanna G

AU - Kuhn, Brett R

AU - Piper, Barbara F.

AU - Farr, Lynne

AU - Agrawal, Sangeeta

AU - Lynch, James C.

AU - Higginbotham, Patti

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Purpose/Objectives: To evaluate the feasibility of an intervention designed to promote sleep and modify fatigue during four cycles of adjuvant breast cancer chemotherapy. Design: Prospective, repeated measures, quasi-experimental feasibility study. Setting: Midwestern urban oncology clinics. Sample: 25 women between the ages of 40-65 (X¯ = 54.3) with stage I-II breast cancer receiving doxorubicinbased chemotherapy. Methods: Each woman developed, reinforced, and revised an individualized sleep promotion plan (ISPP) with four components: sleep hygiene, relaxation therapy, stimulus control, and sleep restriction techniques. A daily diary, the Pittsburgh Sleep Quality Index, a wrist actigraph, and the Piper Fatigue Scale were used to collect data two days before and seven days after each treatment. Main Research Variables: Adherence, sleep and wake outcomes, and fatigue. Findings: Adherence rates with the components of the ISPP varied during treatments one through four: sleep hygiene (68%-78%), relaxation therapy (57%-67%), stimulus control (46%-67%), and sleep restriction (76%-80%). Mean sleep and wake outcomes at baseline, peak, and rebound times were that (a) sleep latency remained brief (less than 30 minutes per night), (b) time awake after sleep onset exceeded the desired less than 30 minutes per night, (c) sleep efficiency scores remained stable at 85%-90%, (d) total rest time remained stable at 8-10 hours per night, (e) subjective ratings of feelings on arising were stable, and (f) nighttime awakenings were 8-10 per night. Fatigue outcomes were that fatigue was stable two days after each treatment and mean daily fatigue intensity was lower at treatment three than at treatment one but rebounded at treatment four. Conclusions: The intervention was feasible, adherence rates improved over time, and most sleep and wake patterns were consistent with normal values. Revisions will focus on decreasing nighttime awakenings. Implications for Nursing: Adopting behaviors to promote sleep may assist in maintaining sleep and managing fatigue during chemotherapy.

AB - Purpose/Objectives: To evaluate the feasibility of an intervention designed to promote sleep and modify fatigue during four cycles of adjuvant breast cancer chemotherapy. Design: Prospective, repeated measures, quasi-experimental feasibility study. Setting: Midwestern urban oncology clinics. Sample: 25 women between the ages of 40-65 (X¯ = 54.3) with stage I-II breast cancer receiving doxorubicinbased chemotherapy. Methods: Each woman developed, reinforced, and revised an individualized sleep promotion plan (ISPP) with four components: sleep hygiene, relaxation therapy, stimulus control, and sleep restriction techniques. A daily diary, the Pittsburgh Sleep Quality Index, a wrist actigraph, and the Piper Fatigue Scale were used to collect data two days before and seven days after each treatment. Main Research Variables: Adherence, sleep and wake outcomes, and fatigue. Findings: Adherence rates with the components of the ISPP varied during treatments one through four: sleep hygiene (68%-78%), relaxation therapy (57%-67%), stimulus control (46%-67%), and sleep restriction (76%-80%). Mean sleep and wake outcomes at baseline, peak, and rebound times were that (a) sleep latency remained brief (less than 30 minutes per night), (b) time awake after sleep onset exceeded the desired less than 30 minutes per night, (c) sleep efficiency scores remained stable at 85%-90%, (d) total rest time remained stable at 8-10 hours per night, (e) subjective ratings of feelings on arising were stable, and (f) nighttime awakenings were 8-10 per night. Fatigue outcomes were that fatigue was stable two days after each treatment and mean daily fatigue intensity was lower at treatment three than at treatment one but rebounded at treatment four. Conclusions: The intervention was feasible, adherence rates improved over time, and most sleep and wake patterns were consistent with normal values. Revisions will focus on decreasing nighttime awakenings. Implications for Nursing: Adopting behaviors to promote sleep may assist in maintaining sleep and managing fatigue during chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0036836193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036836193&partnerID=8YFLogxK

U2 - 10.1188/02.ONF.1431-1441

DO - 10.1188/02.ONF.1431-1441

M3 - Article

C2 - 12432414

AN - SCOPUS:0036836193

VL - 29

SP - 1431

EP - 1441

JO - Oncology Nursing Forum

JF - Oncology Nursing Forum

SN - 0190-535X

IS - 10

ER -